Press release
Instantaneous healthcare backed by 5G to drive the Non-Melanoma Skin Cancer Market at a CAGR of 5.9%
Non-melanoma skin cancer (NMSC) is one of the most common types of skin cancer, which usually occurs in people who have had prolonged exposure to the sun. It includes two types of skin cancer - basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). NMSC is not usually life-threatening, but it can cause significant morbidity and may require extensive surgical intervention, especially in advanced cases. The NMSC market has witnessed significant growth in recent years, owing to the increasing incidence of skin cancer, rising awareness regarding skin cancer, and the availability of new treatment options.Market Overview:
Radiation therapy has a market share approaching 90% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikely to cede this commanding position anytime soon. Radiation therapy has a value of approx. US$ 4.8 Bn by end 2025 making it considerably larger than both chemotherapy and photodynamic therapy. Within radiation therapy, external beam radiation therapy is currently the largest in terms of market value.
However, the highest CAGR of 9.6% for the period 2017-2025 is anticipated to be witnessed in the superficial radiation therapy segment as this newer treatment has relatively lesser side-effects making it preferable for patient health in the long run.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3648
Company Profiles
Admiral SA
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
Elekta AB
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Novartis AG
Mylan NV
Sun Pharmaceutical Industries Ltd.
Varian Medical Systems, Inc.
Sensus Healthcare
iCAD, Inc.
Accuray, Inc.
Ion Beam Applications SA
Drivers and Restraints:
The non-melanoma skin cancer market is primarily driven by factors such as the increasing incidence of skin cancer, growing awareness about skin cancer, and the availability of new treatment options. The rise in the aging population, prolonged exposure to the sun, and the depletion of the ozone layer have resulted in an increased incidence of skin cancer worldwide. Moreover, increasing government initiatives and awareness programs to promote the early diagnosis and treatment of NMSC are also driving market growth. The emergence of new treatment options, including immunotherapy, targeted therapy, and combination therapy, has also contributed to the growth of the NMSC market.
The high cost of treatment, side effects associated with treatments, and the lack of reimbursement policies are some of the major factors that are expected to restrain the growth of the non-melanoma skin cancer market. The high cost of treatment, including surgical intervention and medications, is a major concern for patients, especially in developing countries, which could limit market growth. Additionally, the side effects associated with treatments, such as skin irritation, inflammation, and scarring, could impact patient compliance and hinder market growth. The lack of reimbursement policies for NMSC treatment in some regions could also limit market growth.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3648
Non-Melanoma Skin Cancer Treatment Market - Taxonomy
Treatment Type
Radiation Therapy
External Beam Radiation Therapy
Electronic Brachytherapy
Superficial Radiation Therapy
Chemotherapy
Photodynamic Therapy
Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Indication
Basal Cell Carcinoma
Squamous Cell Carcinoma
End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Access Full Report@ https://www.persistencemarketresearch.com/checkout/3648
Related Reports:
Medical Oxygen Systems Market
https://www.persistencemarketresearch.com/market-research/medical-oxygen-systems-market.asp
Gamma Knife Market
https://www.persistencemarketresearch.com/market-research/gamma-knife-market.asp
Single-Lead ECG Monitors Market
https://www.persistencemarketresearch.com/market-research/single-lead-ecg-machines-market.asp
Herpes Markers Testing Market
https://www.persistencemarketresearch.com/market-research/herpes-markers-testing-market.asp
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Instantaneous healthcare backed by 5G to drive the Non-Melanoma Skin Cancer Market at a CAGR of 5.9% here
News-ID: 3016924 • Views: …
More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market
The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and…

Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts.
Forged automotive components are critical to…

Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the…

Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring…
More Releases for NMSC
Nonmelanoma Skin Cancer Market to Reach New Heights in Growth by 2034, DelveInsi …
The Key Nonmelanoma Skin Cancer Companies in the market include - Genentech, Sanofi, Sirnaomics, AiViva BioPharma, Replimune, Ortho Dermatologics, Philogen S.p.A., AstraZeneca, Pfizer, and others.
DelveInsight's "Nonmelanoma Skin Cancer Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Nonmelanoma Skin Cancer, historical and forecasted epidemiology as well as the Nonmelanoma Skin Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and…
Non Melanoma Skin Cancer (NMSC) Market Insights: Basal Cell and Squamous Cell Ca …
The Global Non Melanoma Skin Cancer Market reached USD 645.7 million in 2022 and is projected to witness lucrative growth by reaching up to USD 911.9 million by 2031. The non melanoma skin cancer market is expected to exhibit a CAGR of 4.5% during the forecast period (2024-2031).
Non Melanoma Skin Cancer Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The…
Non-Melanoma Skin Cancer Market Anticipated to Grow Significantly by 2031 - Pers …
Overview of the Non-Melanoma Skin Cancer Market
The Non-Melanoma Skin Cancer (NMSC) Market is witnessing robust growth owing to the rising prevalence of basal cell carcinoma and squamous cell carcinoma-the two most common types of NMSC. Characterized by high incidence but relatively lower mortality compared to melanoma, NMSC is increasingly being recognized as a serious public health concern, especially in regions with significant exposure to ultraviolet radiation. As per estimates from…
Non-Melanoma Skin Cancer Market is projected to further expand, reaching up to U …
Report Overview
The Global Non-Melanoma Skin Cancer Market has exhibited substantial growth, reaching USD 645.7 million in 2022 and is projected to further expand, reaching up to USD 911.9 million by 2030. The market is anticipated to experience a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period from 2023 to 2030.
Non-melanoma skin cancers, which generally develop in the skin's outermost layer (epidermis), are named after the…
Skin Cancer Diagnostics Market Is Booming Worldwide | Latest Study Reveal for th …
According to our new research study on "Skin Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, and Screening Type," the skin cancer diagnostics market size is expected to reach US$ 5,480.45 million by 2028 from US$ 3,364.46 million in 2021; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028.
Get PDF Sample Report + All Related Table and…
Skin Cancer Diagnostics Market Is Booming Worldwide | Latest Study Reveal for th …
According to our new research study on "Skin Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, and Screening Type," the skin cancer diagnostics market size is expected to reach US$ 5,480.45 million by 2028 from US$ 3,364.46 million in 2021; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028.
Get PDF Sample Report + All Related Table and…